PARENT COMPANY GUARANTEE For the License Agreement by and between Karyopharm Therapeutics Inc. and Antengene Therapeutics Limited effective as of May 23, 2018 (the “Agreement”)
Exhibit 10.2
For the License Agreement by and between Karyopharm Therapeutics Inc. and Antengene Therapeutics Limited effective as of May 23, 2018 (the “Agreement”)
Antengene Corporation Co. Ltd., the parent entity of Antengene Therapeutics Limited, hereby fully and irrevocably guarantees the full, complete and punctual performance of all of the obligations of Antengene Therapeutics Limited to Karyopharm Therapeutics Inc. as described in the Agreement, including those financial obligations set forth in Article 8 of the Agreement. A copy of the Agreement is attached hereto as Appendix A.
| ANTENGENE CORPORATION CO. LTD. | ||
| BY: | /s/ Xxx Xxx | |
| NAME: | Xxx Xxx, MD, PhD | |
| TITLE: | Chief Executive Officer | |
| DATE: May 23, 2018 | ||
Execution Copy
Appendix A: License Agreement
[See Exhibit 10.1 to Form 10-Q]
Execution Copy
